A STUDY OF OTC DRUGS IN INDIA AND REGULATIONS GOVERNING THEM Authors: K. Dheeraj , N.L PRASANTHI1, K.S. NATARAJ, K. RAJA RAJESWARI AND K. VENKATESWARA RAJU*
ABSTRACT
To convert a Rx to an Over-the-counter version, the drug must have some intrinsic characteristics that
make it suitable for self-medication. Although definitions vary by country, the prescription to Over the
counter-switch refers to the conversion of established Rx to OTC classification and done in scenario
where the drug must have an extremely high safety limit, it is used in clearly defined circumstances,
simple to use, the drug's use potentially hazardous conditions are not be concealed. The pandemic of
COVID-19 had a vital effect on the market. India's manufacturers depend largely on Chinese imports
of active pharmaceutical ingredients (APIs). The lockdown slowed API output, resulting in less
accessibility and more material prices for the products. Due to the huge demand for necessary OTC
medications, the government limited the export of some essential medicines. Aside from OTC pain
relievers and fever reducer paracetamol, medicines restricted for export include metronidazole and other
components containing vitamin B1 and B12 as well as antibiotics used to treat bacterial and other
diseases. On the other side, online purchases of over-the-counter medications have increased. For
example, in April 2020, the Andhra Pradesh Medical and Health Department introduced 'Covid
Pharma,' a mobile application to monitor people who buy medicines Over the counter (OTC). This study
focused on OTC drug products, their present status and regulations.
Keywords: Switching, OTC, Rx, DNCE, DNRD, Medications Publication date: 01/04/2024 https://ijbpas.com/pdf/2024/April/MS_IJBPAS_2024_7946.pdfDownload PDFhttps://doi.org/10.31032/IJBPAS/2024/13.4.7946